David Matly - 01 Apr 2025 Form 3 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Role
President
Signature
/s/ Kelly Deck, as attorney-in-fact for David Matly
Issuer symbol
INBX
Transactions as of
01 Apr 2025
Net transactions value
$0
Form type
3
Filing time
02 Apr 2025, 16:31:06 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INBX Stock Option (right to buy) 01 Apr 2025 Common Stock 175,000 $15.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to this stock option will become exercisable on May 30, 2025, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney